Inhibitor of Apoptosis (IAP) proteins in hematological malignancies: molecular mechanisms and therapeutic opportunities

被引：55

作者：

Fulda, S. ^{[1
]}

机构：

[1] Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, D-60528 Frankfurt, Germany

来源：

LEUKEMIA | 2014年 / 28卷 / 07期

关键词：

NF-KAPPA-B; ACUTE MYELOID-LEUKEMIA; X-LINKED INHIBITOR; CHRONIC LYMPHOCYTIC-LEUKEMIA; XIAP ANTISENSE OLIGONUCLEOTIDE; ALPHA-DEPENDENT APOPTOSIS; CASPASE-MEDIATED CLEAVAGE; CELL-DEATH; MULTIPLE-MYELOMA; STRUCTURAL BASIS;

D O I：

10.1038/leu.2014.56

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Inhibitor of Apoptosis (IAP) proteins exert essential functions during tumorigenesis as well as treatment resistance by simultaneously blocking cell death pathways and promoting cell survival. As IAP proteins are typically aberrantly expressed in human cancers including hematological malignancies, they represent in principle promising targets for therapeutic interventions. There are currently exciting opportunities to rationally exploit the therapeutic targeting of IAP proteins for the treatment of leukemia and lymphoma. Further insights into the signaling pathways that are under the control of IAP proteins and into the specific IAP protein-dependent vulnerabilities of hematological neoplasms are expected to pave the avenue to novel treatment strategies.

引用

页码：1414 / 1422

页数：9

共 103 条

[1] A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue [J].

Akagi, T ;

Motegi, M ;

Tamura, A ;

Suzuki, R ;

Hosokawa, Y ;

Suzuki, H ;

Ota, H ;

Nakamura, S ;

Morishima, Y ;

Taniwaki, M ;

Seto, M .

ONCOGENE, 1999, 18 (42) :5785-5794

[2] New wirings in the survivin networks [J].

Altieri, D. C. .

ONCOGENE, 2008, 27 (48) :6276-6284

[3] Opinion - Survivin, cancer networks and pathway-directed drug discovery [J].

Altieri, Dario C. .

NATURE REVIEWS CANCER, 2008, 8 (01) :61-70

[4] Frequent engagement of the classical and alternative NF-κB pathways by diverse genetic abnormalities in multiple myeloma [J].

Annunziata, Christina M. ;

Davis, R. Eric ;

Demchenko, Yulia ;

Bellamy, William ;

Gabrea, Ana ;

Zhan, Fenghuang ;

Lenz, Georg ;

Hanamura, Ichiro ;

Wright, George ;

Xiao, Wenming ;

Dave, Sandeep ;

Hurt, Elaine M. ;

Tan, Bruce ;

Zhao, Hong ;

Stephens, Owen ;

Santra, Madhumita ;

Williams, David R. ;

Dang, Lenny ;

Barlogie, Bart ;

Shaughnessy, John D., Jr. ;

Kuehl, W. Michael ;

Staudt, Louis M. .

CANCER CELL, 2007, 12 (02) :115-130

[5]

[Anonymous], P 102 ANN M AM ASS C

[6] Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern [J].

Ashhab, Y ;

Alian, A ;

Polliack, A ;

Panet, A ;

Ben Yehuda, D .

FEBS LETTERS, 2001, 495 (1-2) :56-60

[7] Directing cancer cells to self-destruct with pro-apoptotic receptor agonists [J].

Ashkenazi, Avi .

NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (12) :1001-1012

[8] cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination [J].

Bertrand, Mathieu J. M. ;

Milutinovic, Snezana ;

Dickson, Kathleen M. ;

Ho, Wai Chi ;

Boudreault, Alain ;

Durkin, Jon ;

Gillard, John W. ;

Jaquith, James B. ;

Morris, Stephen J. ;

Barker, Philip A. .

MOLECULAR CELL, 2008, 30 (06) :689-700

[9] Gene-expression profiling identifies distinct subclasses of core binding factor acute myeloid leukemia [J].

Bullinger, Lars ;

Ruecker, Frank G. ;

Kurz, Stephan ;

Du, Juan ;

Scholl, Claudia ;

Sander, Sandrine ;

Corbacioglu, Andrea ;

Lottaz, Claudio ;

Froehling, Juergen ;

Ganser, Arnold ;

Schlenk, Richard F. ;

Doehner, Konstanze ;

Pollack, Jonathan R. ;

Doehner, Hartmut .

BLOOD, 2007, 110 (04) :1291-1300

[10] XIAP downregulation promotes caspase-dependent inhibition of proteasome activity in AML cells [J].

Carter, Bing Z. ;

Mak, Duncan H. ;

Wang, Zhiqiang ;

Ma, Wencai ;

Mak, Po Yee ;

Andreeff, Michael ;

Davis, R. Eric .

LEUKEMIA RESEARCH, 2013, 37 (08) :974-979

← 1 2 3 4 5 6 7 8 9 10 →